The mechanisms linking defective protein prenylation to systemic inflammation in mevalonate kinase deficiency remain unclear. Munoz et al. reveal that mice and humans with MKD have defective NK cells, with impaired granule trafficking, reduced cytotoxicity, and increased IFN-γ production. Their findings help explain the cause of inflammatory flares in MKD and provide a rationale for testing JAK inhibitor therapy.
